<DOC>
	<DOCNO>NCT00831961</DOCNO>
	<brief_summary>Repeated exposure topical antibiotic may alter normal bacteria eye nose increase rate resistance . This study determine whether repeat short-term exposure topical antibiotic drop commonly prescribe eye injection reduce chance infection increase rate resistant bacteria normally find eye nose . We hypothesis certain commercially available antibiotic may increase rate bacteria resistance others .</brief_summary>
	<brief_title>Antibiotic Resistant Patterns Conjunctival Nasophayngeal Flora After Repeated Exposure Topical Antibiotics</brief_title>
	<detailed_description>Introduction The treatment neovascular age-related macular degeneration ( AMD ) anti-vascular endothelial growth therapy ( ranibizumab bevacizumab , Genentech , South San Francisco , CA ) require repetitive often long-term intraocular injection raise concern increase rate endophthalmitis . Endophthalmitis remain one feared complication ophthalmology despite early detection intervention result substantial morbidity . Recent multicenter clinical trial anti-vascular endothelial growth therapy report endophthalmitis rate 1.0 % 1.9 % per patient treat ( 6 month 2 year period follow-up ) . Consequently , topical antibiotic routinely prescribe intraocular injection , although publish study date prove efficacy prevent post-injection endophthalmitis . 1,2 Of increase concern , however , report grow resistance normal ocular flora commonly employ antibiotic class include macrolides , aminoglycosides , 3rd generation fluoroquinolones.3-5 The recent availability 4th generation fluoroquinolones : gatifloxacin 0.3 % ( Zymar , Allergan Pharmaceuticals , Irvine , Calif ) moxifloxacin 0.5 % ( Vigamox , Alcon Fort Worth , TX ) notably enhance armamentarium widely use due great potency . Not surprisingly however , recent report begin surface document emerge resistance 4th generation fluoroquinolones well.6,7 The practice short-term repeat exposure ocular flora antibiotic , case intraocular injection AMD , may facilitate antibiotic resistance . However , study date evaluate resistance pattern ocular nasopharyngeal flora response repeat application topical antibiotic time . Therefore , study attempt monitor long-term resistance pattern conjunctival nasopharyngeal flora patient AMD repeatedly expose different commercially available antibiotic intraocular injection . Objective Research Study : To determine change ocular nasopharyngeal flora repeat exposure topical antibiotic . Research Hypothesis : Rpeated use topical antibiotic may alter normal ocular nasopharyngeal flora may increase resistance commonly employ antibiotic . Study Design : Prospective , randomize , observational cohort study Specific Goals Study : 1 . Establish baseline susceptibility resistance pattern normal conjunctival nasopharyngeal flora patient choroidal neovascularization . 2 . Monitor change normal conjunctival nasopharyngeal flora repeat exposure topical antibiotic 2 year period . 3 . Determine pattern antibiotic resistance conjunctival nasopharyngeal flora repeat exposure topical antibiotic . Previous Studies : none Methods The Vanderbilt University Institutional Review Board approve study study comply aspects Health Insurance Portability Accountability Act . All adult patient choroidal neovascularization ( CNV ) due AMD cause 1 eye plan treatment intraocular injection either ranibizumab bevacizumab , eligible . Patients exclude young 18 , take concurrent topical systemic antibiotic , active ocular infection , history use topical antibiotic indication within previous 3 month . Patients identified CNV complete ophthalmic examination agree participate ask return ≥ 24 hour later plan injection order minimize contamination topical anesthetic mydriatic drop . Patients assign 1 4 commercially available antibiotic initial study visit : ofloxacin 0.3 % ( Ocuflox , Akorn Inc. , Somerset , NJ ) , azithromycin 1 % ( AzaSite , Inspire Pharmaceuticals , Inc. Durham , NC ) , gatifloxacin 0.3 % , moxifloxacin 0.5 % use assign antibiotic injection entire duration study . Conjunctival culture ( low fornix ) eye nasopharyngeal culture side eye treat take sterile cotton tip applicator calcium alginate swab , respectively application topical medication . The culture obtain standardized fashion every effort make minimize contamination lid , lash , skin . All intravitreal injection perform accordance standard protocol individual treat retina specialist use sterile technique . Patients start use assign antibiotic beginning day injection continue next 4 consecutive day . Conjunctival culture swab transport microbiology laboratory use BBLTM CultureSwabTM ( Becton , Dickinson Company , Sparks , MD 21152 ) transport system inoculate onto blood agar plate incubate 37°C 3 day . All blood agar plate incubate microaerophilic environment . Blood agar culture deem positive 1 colony form unit observe . Nasopharyngeal swab directly inoculate blood agar plate transport microbiology laboratory process . To test resistance , Kirby-Bauer disc diffusion technique conduct accordance guideline National Committee Clinical Laboratory Standards . The following antibiotic test resistance positive culture : penicillin , cefazolin , ceftazidime , imipenem , gentamicin , tobramycin , erythromycin , azithromycin , ciprofloxacin , ofloxacin , levofloxacin , gatifloxacin , moxifloxacin , doxycycline , vancomycin . All patient return 4 week culture retaken exact fashion . If injection plan , protocol repeat end study . Sample Size Exact sample size calculation difficult give absence reference data . We plan follow patient 2 year anticipate require 10 patient antibiotic arm . We anticipate 6 culture result per patient first year follow-up assume 20 % loss follow-up . Thus , plan recruit total 48 participant . Statistics Descriptive statistic include mean standard deviation calculate case characteristic . Group comparison perform Wilcoxon rank-sum test chi-square test . A P value &lt; 0.05 consider significant . Study Withdrawal : patient remind every visit discontinue study time . Patient information : patient data record retained use non-identifiers .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>age great 18 choroidal neovascularization plan treatment intravitreal injection Use topical antibiotic reason within 3 month , current use systemic topical antibiotic , know allergy gatifloxacin , moxifloxacin , ofloxacin , azithromycin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Antibiotic resistance , Conjunctival flora , Intravitreal injection</keyword>
</DOC>